Submit a newsroom tip
Subscribe to the Daily Pulse Browse the archive
Live Wire
BREAKING
Japan name 20-player roster for 2026 Japan All-Star Series against USA – World Baseball Softball Confederation (WBSC)Russia’s naval posture in the Mediterranean has ‘significantly decreased’: NATO official – Breaking DefenseChina’s $35B Nvidia GPU Order Tests Export Limits [2026] – shattered.ioShopMy Backer Inspired Capital Closes on $450 Million Fund, Bets on Creators and AI to Reshape RetailChina Wins Big at World Rowing Beach Sprint Finals – Rowing NewsRubio pushes for India to buy more U.S., Venezuelan oilBangladesh Sangbad Sangstha (BSS) – Bangladesh Sangbad Sangstha (BSS)Cardiologists from across the globe discuss angioplasty complications at meet in ChennaiSheikh Hasina's Son Accuses Biden Administration of Role in Bangladesh's 2024 Political Upheaval – INDIA New England NewsKanthapuram Sunni faction calls off protests against Waqf board reconstitution in KeralamAustralia’s live performance industry sees marginal drops in overall ticket revenue and attendance – Australasian Leisure Management MagazineWrangler’s New Collection Keeps the Hay Away

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
📰
Sourced From
TechCrunch
Read Full Article →

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Source: TechCrunch — Read full article →

Content sourced from third parties. Copyright belongs to original publishers.

Share this story

WhatsAppXFacebookLinkedInThreadsTelegram

admin2026

Leave a Reply

Your email address will not be published. Required fields are marked *